...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Synthesis of novel benzofuran isoxazolines as protein tyrosine phosphatase 1B inhibitors.
【24h】

Synthesis of novel benzofuran isoxazolines as protein tyrosine phosphatase 1B inhibitors.

机译:新型苯并呋喃异恶唑啉作为蛋白质酪氨酸磷酸酶1B抑制剂的合成。

获取原文
获取原文并翻译 | 示例
           

摘要

PTPases are considered to be involved in the etiology of diabetes mellitus and neural diseases, such as Alzheimer's disease and Parkinson's disease. Therefore, PTPase inhibitors should be useful tools to study the role of PTPases in these diseases and other biological phenomena, and which can be developed into chemotherapeutic agents. In the present study, we have synthesized novel benzofuran isoxazolines 13-21 via 1,3-dipolar cycloaddition reaction using karanjin (1) and kanjone (2), isolated from Pongamia pinnata fruits. All the synthesized compounds were evaluated against PTPase enzyme. Compounds 19 and 20 displayed significant inhibitory activity with IC50 values 76 and 81 microM, respectively.
机译:PTP酶被认为与糖尿病和神经疾病例如阿尔茨海默氏病和帕金森氏病的病因有关。因此,PTPase抑制剂应该是研究PTPase在这些疾病和其他生物学现象中的作用的有用工具,并可以发展成为化学治疗剂。在本研究中,我们使用分离自Pongamia pinnata果实的karanjin(1)和kanjone(2)通过1,3-偶极环加成反应合成了新型苯并呋喃异恶唑啉13-21。所有合成的化合物均针对PTPase酶进行了评估。化合物19和20表现出明显的抑制活性,IC50分别为76和81 microM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号